BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11002571)

  • 21. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
    Nakamura K; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2011 Oct; 123(1):82-7. PubMed ID: 21764107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA-125) in carcinoma of the endometrium.
    Yu B; Xu PZ; Wang QW; Zhou H; Zhou HX
    J Int Med Res; 2009; 37(3):878-83. PubMed ID: 19589273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors.
    Sala P; Moran E; Paolucci R; Menoni S; Fulcheri E; Costantini S; Valenzano Menada M
    Minerva Ginecol; 2016 Feb; 68(1):21-8. PubMed ID: 26990099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions.
    Osmanağaoğlu MA; Erdoğan I; Eminağaoğlu S; Karahan SC; Ozgün S; Can G; Bozkaya H
    J Obstet Gynaecol; 2010 Apr; 30(3):288-93. PubMed ID: 20373934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative CA-125, CA 19-9 and nuclear magnetic resonance in endometrial carcinoma: correlation with surgical stage.
    Schneider J; Centeno M; Sáez F; Genollá J; Ruibal A
    Tumour Biol; 1999; 20(1):25-9. PubMed ID: 9858872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
    Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
    Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
    Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring endometrial adenocarcinoma with a four tumor marker combination. CA 125, squamous cell carcinoma antigen, CA 19.9 and CA 15.3.
    Matorras R; Rodríguez-Escuderoi FJ; Diez J; Genollá J; Cruz Fombellida J; Ruibal A
    Acta Obstet Gynecol Scand; 1992 Aug; 71(6):458-64. PubMed ID: 1326844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients].
    Grzybowski W; Beta J; Fritz A; Durczyński A; Bidziński M; Grabiec M; Jakimiuk AJ
    Ginekol Pol; 2010 Jul; 81(7):511-5. PubMed ID: 20825052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
    Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of a single serum CA-125 level in women with symptoms of imminent abortion during the first trimester of pregnancy.
    Fiegler P; Katz M; Kaminski K; Rudol G
    J Reprod Med; 2003 Dec; 48(12):982-8. PubMed ID: 14738027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
    Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of gynecological cytology and CA 125 level for the prediction of extrauterine malignancy in endometrial cancer].
    Brassard L; Bessette P
    J Obstet Gynaecol Can; 2012 Jul; 34(7):657-63. PubMed ID: 22742485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma.
    Kurihara T; Mizunuma H; Obara M; Andoh K; Ibuki Y; Nishimura T
    Gynecol Oncol; 1998 Jun; 69(3):192-6. PubMed ID: 9648586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive power of sexual hormones and tumor markers in endometrial cancer.
    Kanat-Pektas M; Yenicesu O; Gungor T; Bilge U
    Arch Gynecol Obstet; 2010 Apr; 281(4):709-15. PubMed ID: 19777250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma.
    Uçkaya G; Ozet A; Arpaci A; Kömürcü S
    Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.